Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Roumell Sells a Small Amount of Transcept Pharmaceuticals

Jim Roumell‘s Roumell Asset Management reported reducing its position in Transcept Pharmaceuticals Inc (NASDAQ:TSPT) to some 2.3 million shares. According to a new Form 4, Roumell sold 7,020 shares in four transactions, with the price varying between $3.65 and $3.85 apiece.

James Roumell

Disclosure: none

Loading...